Skip to main content
. 2020 May 8;41(5):291–298. doi: 10.4082/kjfm.18.0129

Table 3.

Results from multivariate linear regression analysis of the associations of relative handgrip strength (strength/BMI) and dominant handgrip strength (kg) with cardiometabolic markers

Predictor Men
Women
Aged 20–64 y
Aged 65–80 y
Aged 20–64 y
Aged 65–80 y
β (95% CI) P-value β (95% CI) P-value β (95% CI) P-value β (95% CI) P-value
Dominant hand grip strength (kg)
 BMI (kg/m2) 0.65 (0.46 to 0.85) <0.001 0.21 (-0.13 to 0.56) 0.218 0.18 (0.07 to 0.29) 0.002 0.10 (-0.07 to 0.27) 0.241
 WC (cm) -0.07 (-0.14 to 0.00) 0.062 0.06 (-0.05 to 0.17) 0.263 0.04 (0.00 to 0.09) 0.045 0.02 (-0.05 to 0.08) 0.613
 SBP (mm Hg) -0.01 (-0.04 to 0.02) 0.614 -0.01 (-0.03 to 0.02) 0.633 -0.03 (-0.05 to 0.00) 0.019 0.01 (-0.01 to 0.03) 0.430
 DBP (mm Hg) 0.03 (-0.01 to 0.08) 0.118 0.06 (0.00 to 0.12) 0.042 0.05 (0.02 to 0.08) 0.001 0.01 (-0.03 to 0.05) 0.639
 TG (mg/dL) 0.00 (0.00 to 0.00) 0.402 0.00 (0.00 to 0.01) 0.365 0.00 (-0.01 to 0.00) 0.020 0.00 (-0.01 to 0.00) 0.396
 HDL (mg/dL) 0.01 (-0.02 to 0.04) 0.485 0.06 (0.02 to 0.09) 0.005 -0.01 (-0.03 to 0.00) 0.187 0.02 (-0.01 to 0.04) 0.248
 LDL (mg/dL) 0.00 (-0.01 to 0.01) 0.903 0.01 (0.00 to 0.02) 0.079 -0.01 (-0.01 to 0.00) 0.118 0.00 (-0.01 to 0.01) 0.672
 Fasting glucose (mg/dL) -0.01 (-0.03 to 0.02) 0.604 0.01 (-0.01 to 0.04) 0.418 0.02 (0.00 to 0.03) 0.112 0.01 (-0.01 to 0.03) 0.178
 HbA1C (%) 0.18 (-0.40 to 0.75) 0.544 -0.68 (-1.45 to 0.10) 0.086 -0.31 (-0.82 to 0.19) 0.225 0.02 (-0.57 to 0.61) 0.951
 hsCRP (mg/L) -0.19 (-0.29 to -0.08) <0.001 -0.12 (-0.25 to 0.01) 0.069 -0.09 (-0.17 to -0.01) 0.028 -0.14 (-0.27 to 0.00) 0.045
 Physical activity (min/wk) 0.01 (0.00 to 0.01) <0.001 0.01 (0.00 to 0.01) 0.022 0.01 (0.00 to 0.01) 0.009 0.00 (0.00 to 0.01) 0.471
 Diabetes -1.37 (-2.72 to -0.02) 0.046 0.22 (-1.15 to 1.59) 0.754 -1.38 (-2.48 to -0.27) 0.015 -1.23 (-2.36 to -0.09) 0.035
 Dyslipidemia 0.43 (-0.28 to 1.15) 0.235 0.22 (-0.80 to 1.24) 0.668 0.24 (-0.20 to 0.68) 0.284 0.68 (-0.21 to 1.58) 0.136
 R2 0.10 0.25 0.06 0.17
Relative hand grip strength (kg/BMI)
 BMI (kg/m2) -0.08 (-0.09 to -0.06) <0.001 -0.10 (-0.12 to -0.07) <0.001 -0.07 (-0.08 to -0.06) <0.001 -0.06 (-0.07 to -0.04) <0.001
 WC (cm) -0.01 (-0.01 to 0.00) 0.073 0.01 (0.00 to 0.01) 0.230 0.00 (0.00 to 0.01) 0.080 0.00 (0.00 to 0.01) 0.598
 SBP (mm Hg) 0.00 (0.00 to 0.00) 0.509 0.00 (0.00 to 0.00) 0.952 0.00 (0.00 to 0.00) 0.015 0.00 (0.00 to 0.00) 0.398
 DBP (mm Hg) 0.00 (0.00 to 0.01) 0.065 0.01 (0.00 to 0.01) 0.024 0.00 (0.00 to 0.01) <0.001 0.00 (0.00 to 0.00) 0.526
 TG (mg/dL) 0.00 (0.00 to 0.00) 0.519 0.00 (0.00 to 0.00) 0.408 0.00 (0.00 to 0.00) 0.009 0.00 (0.00 to 0.00) 0.111
 HDL (mg/dL) 0.00 (0.00 to 0.00) 0.052 0.00 (0.00 to 0.01) 0.003 0.00 (0.00 to 0.00) 0.634 0.00 (0.00 to 0.00) 0.683
 LDL (mg/dL) 0.00 (0.00 to 0.00) 0.815 0.00 (0.00 to 0.00) 0.149 0.00 (0.00 to 0.00) 0.017 0.00 (0.00 to 0.00) 0.959
 Fasting glucose (mg/dL) 0.00 (0.00 to 0.00) 0.276 0.00 (0.00 to 0.00) 0.197 0.00 (0.00 to 0.00) 0.085 0.00 (0.00 to 0.00) 0.114
 HbA1C (%) 0.03 (-0.01 to 0.07) 0.175 -0.06 (-0.12 to 0.00) 0.067 -0.02 (-0.06 to 0.02) 0.327 -0.01 (-0.06 to 0.03) 0.600
 hsCRP (mg/L) -0.01 (-0.02 to -0.01) <0.001 -0.01 (-0.02 to 0.00) 0.122 -0.01 (-0.01 to 0.00) 0.034 -0.01 (-0.02 to 0.00) 0.029
 Physical activity (min/wk) 0.00 (0.00 to 0.00) <0.001 0.00 (0.00 to 0.00) 0.009 0.00 (0.00 to 0.00) 0.011 0.00 (0.00 to 0.00) 0.126
 Diabetes -0.12 (-0.22 to -0.02) 0.017 -0.03 (-0.14 to 0.08) 0.595 -0.10 (-0.18 to -0.02) 0.020 -0.08 (-0.17 to 0.01) 0.085
 Dyslipidemia 0.01 (-0.05 to 0.06) 0.847 0.00 (-0.09 to 0.08) 0.950 0.01 (-0.02 to 0.05) 0.428 0.06 (-0.01 to 0.14) 0.083
 R2 0.31 0.35 0.33 0.30

Values are from linear regression analysis; coefficients are unstandardized. Age was adjusted for in the multivariate linear model.

BMI, body mass index; CI, confidence interval; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; TG, triglycerides; HDL, high-density lipoprotein; LDL, low-density lipoprotein; HbA1C, hemoglobin A1c; hsCRP, high-sensitivity C-reactive protein.